Hôpital Cochin
Paris, 75014, France
NCT Number: NCT00804531
To assess the efficacy on pain level at 1 month and 12 months of a steroid injection in the inter-vertebral disc for patients with chronic back pain and inflammatory discopathy on magnetic resonance imaging.
Hypothesis: delivering anti-inflammatory drugs in situ may decrease back pain in patients with inflammatory discopathy
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 4
Paris, 75014, France
Objective: to assess the efficacy on pain level of a steroid injection in the inter-vertebral disc for patients with chronic back pain and MODIC I discopathy on MRI
Methods: a multicenter double blind randomized control trial Setting: 3 tertiary care hospitals in France Patients: 134 patients with disabling chronic low back pain not relieved by usual recommended treatments and MODIC I (inflammatory) discopathy on MRI Intervention: Injection of 25 mg of methylprednisolone in the inter-vertebral disc during a discography (intervention group, 67 patients) or discography alone (control group, 67 patients) Outcome measures: The primary outcome measure is pain level assessed on a 11-point numeric scale (0-100) at 1 month. Success is defined as less than 40 on pain numeric scale at 1 month. Secondary outcome measures are pain level at 12 months, Disability (Quebec questionnaire), quality of life (SF-12) at 1 and 12 months, anxiety and depression (HAD), analgesics and anti-inflammatories during the last week, return to work, assessment of the disabilities at 1 and 12 months and disc inflammation (on MRI) at 12 months. Tolerance and adverse effects will be recorded.
Trial duration: 36 months(24 months for inclusion and 12 months follow-up) Follow-up visits: at 1, 3, 6, and 12 months Statistical analysis: intention to treat
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Non inclusion criteria :
Visipaque 320 mg I/ml - 1 ml intra-discal route Hydrocortancyl 25 mg/ml - 1 ml intra-discal route
Visipaque - 320 mg I/ml - 1 ml in intra-discal route
Time frame: 1 month
Time frame: 12 months
Time frame: 1 month and 12 months
Time frame: 1 month and 12 months
Time frame: 1 month and 12 months
Time frame: 12 months
Time frame: 1 month and 12 months
Time frame: 1 month and 12 months
Time frame: 1 month and 12 months
Assistance Publique - Hôpitaux de Paris
Other
Intra-discal Steroid Injection for MODIC I Discopathy: A Randomized Control Trial
Acronym: PREDID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03106740
Back Ache, Back Pain
Charlestown, Massachusetts, United States
View Trial DetailsNCT06969508
Back Pain, Back Pain Lower Back Chronic
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03338192
Back Pain, Back Pain Lower Back Chronic
Birmingham, Alabama, United States
View Trial DetailsNCT06064058
Back Pain, Back Pain Lower Back Chronic
Baghdad, Iraq
View Trial Details